Celmatix

Recent Finacing

Non-Equity

Recent Raise

$3.5M

Celmatix is a women's health company developing ovarian-targeted therapeutics (AMHR2 agonists, oral FSH) and genomics-driven diagnostics/analytics (Polaris, Polaris X, FertilArray) to guide fertility treatment.

Founded 2009

New York, United States

101-250

Private

celmatix.com